UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Date of report (Date of earliest event reported): September 25, 2015

 

Xtant Medical Holdings, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

333-158426 20-5313323
(Commission File Number)

(IRS Employer Identification No.)

 

664 Cruiser Lane

Belgrade, Montana

 59714
(Address of Principal Executive Offices)

(Zip Code)

 

(406) 388-0480

(Registrant’s Telephone Number, Including Area Code)

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

Item 5.03Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On September 25, 2015, the Company’s Board of Directors unanimously approved and adopted the Amended and Restated Bylaws attached as Exhibit 3.2 to this Current Report on Form 8-K to reflect the Company’s recent name change from Bacterin International Holdings, Inc. to Xtant Medical Holdings, Inc.

 

Item 9.01.Financial Statements and Exhibits.

 

(d)  Exhibits.

 

Exhibit No   Description
     
3.2   Amended and Restated Bylaws of Xtant Medical Holdings, Inc., as amended and restated effective September 25, 2015.

 

 

 

 

 

 

SIGNATURE

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated:  September 30, 2015 XTANT MEDICAL HOLDINGS, INC.  
       
       
       
  By:   /s/ John Gandolfo  
  Name:   John Gandolfo  
  Title:   Chief Financial Officer  

 

 

 

 

EXHIBIT INDEX

 

 

3.2   Amended and Restated Bylaws of Xtant Medical Holdings, Inc., as amended and restated effective September 25, 2015.